These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36826665)

  • 1. [Deprescribing in nursing homes - which drugs and when?].
    Püllen R
    MMW Fortschr Med; 2023 Mar; 165(4):38-41. PubMed ID: 36826665
    [No Abstract]   [Full Text] [Related]  

  • 2. Nursing home team-care deprescribing study: a stepped-wedge randomised controlled trial protocol.
    Kua CH; Yeo CYY; Char CWT; Tan CWY; Tan PC; Mak VS; Lee SWH; Leong IY
    BMJ Open; 2017 May; 7(5):e015293. PubMed ID: 28490560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deprescribing in Nursing Home Residents on Polypharmacy: Incidence and Associated Factors.
    Onder G; Vetrano DL; Villani ER; Carfì A; Lo Monaco MR; Cipriani MC; Manes Gravina E; Denkinger M; Pagano F; van der Roest HG; Bernabei R
    J Am Med Dir Assoc; 2019 Sep; 20(9):1116-1120. PubMed ID: 30853425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unlocking Deprescribing Potential in Nursing Homes: Insights from a Focus Group Study with Healthcare Professionals.
    Visser AGR; de-Bruijn JBGP; Spaetgens B; Winkens B; Janknegt R; Schols JMGA
    Drugs Aging; 2024 Mar; 41(3):261-270. PubMed ID: 38285238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Deprescribing in nursing homes: comparative views of residents, their relatives, and healthcare professionals].
    Cateau D; Foley RA; Niquille A
    Rev Med Suisse; 2020 Nov; 16(714):2169-2171. PubMed ID: 33174699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deprescribing in nursing homes: Protocol for nested, randomised controlled hybrid trials of deprescribing interventions.
    Cateau D; Ballabeni P; Mena S; Bugnon O; Niquille A
    Res Social Adm Pharm; 2021 Apr; 17(4):786-794. PubMed ID: 32622774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "I simply don't know, because I don't know which drugs I get": Perspectives on deprescribing among older adults with limited life expectancy and their relatives.
    Graabaek T; Lundby C; Ryg J; Søndergaard J; Pottegård A; Nielsen DS
    Basic Clin Pharmacol Toxicol; 2021 Jan; 128(1):115-127. PubMed ID: 32770703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Deprescribing antihypertensive therapy].
    Tebib N; Wuerzner G
    Rev Med Suisse; 2020 Sep; 16(706):1690-1692. PubMed ID: 32936550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [MEDICATIONS DEPRESCRIBING IN ELDERLY NURSING HOME RESIDENTS].
    Aizen E; Hindawil E; Hijazi M; Merih A; Shahla H; Elyounes AA
    Harefuah; 2016 Mar; 155(3):145-9, 197. PubMed ID: 27305746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of an interprofessional Quality Circle-Deprescribing Module (QC-DeMo) in Swiss nursing homes: a randomised controlled trial.
    Cateau D; Ballabeni P; Niquille A
    BMC Geriatr; 2021 May; 21(1):289. PubMed ID: 33933030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isn't It Time We Stop Counting the Number of Drugs to Define Polypharmacy in This New Era of Deprescribing and What Related Outcomes Should Be Measured?
    Hanlon JT; Hajjar ER
    J Am Med Dir Assoc; 2018 Aug; 19(8):644-645. PubMed ID: 29861195
    [No Abstract]   [Full Text] [Related]  

  • 12. Perspectives of health professionals towards deprescribing practice in Asian nursing homes: a qualitative interview study.
    Kua CH; Mak VS; Lee SWH
    BMJ Open; 2019 Oct; 9(10):e030106. PubMed ID: 31604786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
    Rozsnyai Z; Jungo KT; Reeve E; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    BMC Geriatr; 2020 Oct; 20(1):435. PubMed ID: 33129274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spread and scale of an electronic deprescribing software to improve health outcomes of older adults living in nursing homes: study protocol for a stepped wedge cluster randomized trial.
    Nadeau ME; Henry JL; Lee TC; Bortolussi-Courval É; Goodine C; McDonald EG
    Trials; 2021 Nov; 22(1):763. PubMed ID: 34727956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Policies Shaping Nursing Home Medication Practices: Involving Nurses to Advance Individualized Deprescribing.
    Block LM; Maust DT; Roberts TJ
    J Gerontol Nurs; 2023 Sep; 49(9):15-20. PubMed ID: 37650847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial.
    Balsom C; Pittman N; King R; Kelly D
    Int J Clin Pharm; 2020 Aug; 42(4):1153-1167. PubMed ID: 32494991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deprescribing in older people.
    O'Mahony MS; Parbhoo A
    Br J Hosp Med (Lond); 2020 Jan; 81(1):1-9. PubMed ID: 32003625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Deprescribing With Reduction in Mortality and Hospitalization: A Pragmatic Stepped-Wedge Cluster-Randomized Controlled Trial.
    Kua CH; Yeo CYY; Tan PC; Char CWT; Tan CWY; Mak V; Leong IY; Lee SWH
    J Am Med Dir Assoc; 2021 Jan; 22(1):82-89.e3. PubMed ID: 32423694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polypharmacy is an indicator for a poor prognosis, which is not altered by deprescribing in nursing home].
    Schönenberger T; Rauber S; Hauser N; Roth M; Wettstein A; Schönenberger PM
    Praxis (Bern 1994); 2011 Feb; 100(4):213-20. PubMed ID: 21328235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland.
    Zechmann S; Trueb C; Valeri F; Streit S; Senn O; Neuner-Jehle S
    BMC Fam Pract; 2019 May; 20(1):64. PubMed ID: 31088397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.